American Academy of Ophthalmology
On Friday 11th October, London Medical’s very own retinal ophthalmology expert Philip Hykin presented a major research paper to over 3000 retina specialists at the annual meeting of the American Acadaemy of Ophthalmology in San Francisco.
The paper – ‘A Multicenter Phase 3 Double-Masked Randomized Controlled Noninferiority Trial Comparing the Clinical and Cost Effectiveness of Lucentis vs. Eylea vs. Avastin in Macula Edema Due to Central Retinal Vein Occlusion (LEAVO)’ – offers ophthalmologists greater insight into the cost-effectiveness and efficacy of some of the most popular anti-VEGF treatments for patients with macular edema due to central retinal vein occlusion.
Search treatments & services A-Z
Search for a specific treatment or service.
In other news
Experience unmatched breast care at our innovative one-stop breast clinic
London Medical is proud to offer patients same-day breast diagnostics at our...
Bupa Health Services acquires London Medical
Bupa Health Services is pleased to announce a new partnership and the...
New service at London Medical
We're excited to announce the launch of our new Outpatient Paediatric Cardiology...